atezolizumab,nivolumab,sacituzumab,pembrolizumab
roche,bms,gilead sciences,merck
['nsclc', 'impower,10', 'sclc', 'pearls', 'key,note,42', 'impower,30', 'nivo', ' sg ', 'impower010', 'check,mate,816', 'checkmate 816', 'keynote,91', 'nivolumab', 'nadim ii', 'key,note,57']
immunotherapy for nsclc . great slides from talk by #esmoimmuno22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists